Keywords
Misoprostol
Cesarean section
Postoperative bleeding
Submitted : 2025-04-08
Accepted : 2025-04-23
Published : 2025-05-08
Abstract
Objective: This study is to analyze the value of combining misoprostol and oxytocin in the prevention and control of postpartum hemorrhage during cesarean section. Methods: 82 cesarean section patients from July 2023 to July 2024 were selected as samples and randomly divided into two groups. Group A received misoprostol combined with oxytocin treatment, while Group B received only misoprostol treatment. The amount of postpartum hemorrhage, coagulation indicators, postpartum recovery indicators, and adverse reactions were compared between the two groups. Results: The intraoperative, 2-hour postpartum, 2-24-hour postpartum, and total blood loss in Group A were all lower than those in Group B (P < 0.05). The activated partial thromboplastin time (APTT), plasma prothrombin time (PT), fibrinogen (FIB), and thrombin time (TT) in Group A were all lower than those in Group B (P < 0.05). The first exhaust time, first time out of bed, and hospital stay after cesarean section in Group A were all shorter than those in Group B (P < 0.05). The adverse reaction rate in Group A was lower than that in Group B (P < 0.05). Conclusion: The application of misoprostol combined with oxytocin during cesarean section can optimize coagulation indicators, reduce blood loss, shorten postpartum recovery time, and is highly effective and feasible.
References
Wang Y, Su D, 2024, Evaluation of the Effect of Misoprostol Combined with Oxytocin in Preventing Postpartum Hemorrhage in Cesarean Section Patients. Practical Gynecological Endocrinology Electronic Journal, 11(16): 71–73.
Zhao Y, Qi H, Wei Y, 2024, Expert Consensus on Cesarean Section Surgery (2023). Chinese Journal of Obstetrics and Gynecology, 59(1): 14–21.
Song Y, Guo T, 2024, The Effect of Ergometrine Maleate Combined with Oxytocin and Misoprostol in Preventing Postpartum Hemorrhage After Secondary Cesarean Section and Its Impact on Hemodynamics. Clinical Medical Research and Practice, 9(23): 78–81.
Du Y, Ma Y, Peng D, 2022, Clinical Application Analysis of Modified Uterine Bundling Technique Combined with Carboprost Tromethamine-Misoprostol Treatment for Uterine Atony Postpartum Hemorrhage After Cesarean Section. Chinese Journal of Clinical Obstetrics and Gynecology, 23(1): 81–82.
Ma Y, 2020, Clinical Effect of Carboprost Tromethamine Combined with Modified B-Lynch Surgery in the Treatment of Intractable Uterine Atony Postpartum Hemorrhage. Henan Medical Research, 29(35): 6597–6599.
Lin W, Li H, 2021, Effectiveness and Safety Analysis of Shrinking Uterus and Restoring Old Soup Combined with Misoprostol and Mifepristone in the Treatment of Missed Abortion. Laboratory Medicine and Clinic, 18(19): 2905–2908.
Wang X, 2019, Clinical Study on the Treatment of Missed Abortion with Shrinking Uterus and Dispelling Blood Stasis Decoction Combined with Mifepristone and Misoprostol. New Chinese Medicine, 51(4): 196–199.
Wang T, Zhang Y, Zhang Y, 2021, Therapeutic Effect Analysis of Mifepristone and Misoprostol Pretreatment Combined with Hysteroscopy for Type II Cesarean Scar Pregnancy. Chinese Journal of Modern Applied Pharmacology, 38(1): 87–90.
Xiao T, Zhou J, 2024, Effect Analysis of Oxytocin Combined with Misoprostol in the Treatment of Uterine Atony Postpartum Hemorrhage. Practical Gynecological Endocrinology Electronic Journal, 11(8): 62–64.
Bao C, Li L, 2024, Application Effect of Carboprost Tromethamine in Patients with Uterine Atony Postpartum Hemorrhage and Its Impact on Uterine Contraction and Blood Indices. Chinese Medical Innovation, 21(33): 155–158.
Sun S, Wang L, Yin L, 2024, Discussion on the Effect of Misoprostol Combined with Ergometrine Maleate in the Treatment of Postpartum Hemorrhage After Cesarean Section. Systems Medicine, 9(20): 147–150.
Ma S, 2024, Clinical Efficacy of Hemabate, Misoprostol Combined with Uterine Strap Suture in the Treatment of Uterine Atony Bleeding After Cesarean Section. Chinese Science and Technology Journal Database (Abstract Version) Medicine and Health, 2024(8): 17–20.
Zhao L, 2024, The Efficacy of Misoprostol in the Clinical Application of Obstetrics on Postpartum Hemorrhage. Chinese Science and Technology Periodical Database Medicine, 2024(8): 1–4.
Dai C, 2024, To Explore the Therapeutic Effect of Misoprostol on Postpartum Hemorrhage in Obstetrics Clinical Application. Practical Gynecological Endocrinology Electronic Journal, 11(11): 52–54+58.
Qu J, Xu J, 2024, Effect of Uterine Balloon Tamponade Combined with Carboprost Tromethamine-Misoprostol in the Treatment of Uterine Atony Postpartum Hemorrhage After Cesarean Section and Its Impact on Uterine Hemodynamics. Clinical Medical Research and Practice, 9(25): 159–162.